October 2024 brought 4 new FDA drug approvals in the oncology space. With new drug regimens in both the solid tumor and blood ...

The FDA expanded the approval of methotrexate to include patients with pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis. The FDA approval of methotrexate (Jylamvo ...

The FDA granted an accelerated approval to asciminib for newly diagnosed Ph+ chronic myeloid leukemia in the chronic phase.

“You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led ...

While pregnancy-associated cancer risks increased with age, breast cancer during pregnancy tended to not impact obstetric ...

An expert discussed fam-trastuzumab deruxtecan-nxki for HER2-mutant and -overexpressing non-small cell lung cancer.

Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS ...

Research is analyzing the effect of imtermittent fasting on quality of life outcomes in patients undergoing radiation therapy.

Early Symptom Detection and the Impact on Patient Outcomes in GVHD ...

Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS ...